Notice Type
Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Mesalazine 400 mg Tablet SmithKline Beecham Pharma GmbH, Gronau/Leine, Germany Asacol Famotidine 20 mg, 40 mg Wafer R P Scherer, Blagrove, Swindon, Wiltshire, England Pepcidine RPD Cilazapril 5 mg, hydrochlorothiazide 12.5 mg Tablet F Hoffmann-La Roche & Co, Aktiengesellschaft, Basle, Switzerland Inhibace Plus Human Menopausal Gonadotrophin FSH 75IU/LH 35IU, FSH 150IU/LH 70IU Lyophilisate for IM injection Industria Farmaceutica Serono, Roma, Italy Pergogreen Polyhexamethylene biguanide 0.0001% w/v, tromethamine 1.2% w/v, tyloxapol 0.025% w/v Contact lens cleaning solution Allergan Optical, Allergan Inc., Waco, Texas, United States of America and Allergan Pharmaceuticals (Ireland) Limited, Westport, County Mayo, Ireland Complete All-In One Vancomycin hydrochloride 500 mg, 1 g Powder for reconstitution for injection Lyphomed Inc., Melrose Park, Illinois, United States of America Lyphocin Injection Dated this 17th day of February 1994. C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1993.
Publication Date
24 Feb 1994

Notice Number


Page Number